Deltex Medical Regulatory News (DEMG)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, RUSSIA, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A BREACH OF THE RELEVANT SECURITIES LAWS OF SUCH JURISDICTION.

This Announcement does not constitute a prospectus or offering memorandum or an offer in respect of any securities and is not intended to provide the basis for any investment decision in respect of Deltex Medical Group plc or other evaluation of any securities of Deltex Medical Group plc or any other entity and should not be considered as a recommendation that any investor should subscribe for or purchase any such securities.

24 January 2018

Deltex Medical Group plc

("Deltex" or the "Company")

Posting of Circular

Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring ("ODM"), announces that it has today posted a Circular to shareholders concerning the Capital Raising announced on 23 January 2018 which will be made available on the Company's website at www.deltexmedical.com.

With regard to the Offer element of the Capital Raising, Qualifying Shareholders will also receive an Application Form enabling them to apply for, in aggregate, up to 28,000,000 new Ordinary Shares at a price of 1.25p per share to raise up to £350,000 (gross).

Capitalised terms used in this announcement shall have the same meanings as the definitions in the Company's announcement of 23 January 2018 and in the Circular.

For further information please contact: